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Introduction
Treatment with second line ART is initiated when the
first line therapy fails. There is less experience with the
immunologic response for second-line ART for adults.
Hence this study was done to find out the immunological
response after initiation of second line ART by analysis
of CD4 counts.
Methods
This retrospective study was conducted in a tertiary level
hospital attached to a medical college that caters to a large
number of HIV positive patients. The study population for
this analysis included all HIV positive individuals who
were undergoing second line ART treatment.The data was
collected using semi-structured pre-tested proforma from
the hospital records of HIV positive individuals. The
immunological response after the initiation of second line
ART was analyzed using the CD4 cell counts taken at
intervals of 3 months and 6 months after the initiation.
Results
Out of the 32 patients studied, 27(84.4%) were males and
only 5(15.6%) were females. Mean age of the patients was
40.56±6.78 years. The mean CD4 value at initiation was
152.35±142.89cells/μL, which significantly increased to
324.43 ±163.65cells /μLby 3 months after initiation (p
value= .000) and to 348.21± 253.57cells /μLby 6 months
after initiation.Around 91.3% of patients had a baseline
CD4 T cell count <350 cells L-6. After 3 months of ther-
apy, 65.2% of patients and after 6 months 46.2% had a
baseline CD4 T cell count <350 cells /μL.The mean
weight at initiation was 50.548± 11.37 kg, which very sig-
nificantly increased to 53.30± 11.1 kg by 3 months of
therapy (p = .001, table 1) and to 54.63 ± 10.29kg at the
end of 6 months.
Conclusion
The CD4 counts increase very significantly within the first
3m o n t h so fi n i t i a t i o no fs e c o n dl i n et h e r a p y . T h er i s ei n
CD4 count between 3 months and 6 months is not as sta-
tistically significant as the earlier one. Also, there is signifi-
cant gain in weight within 6 months of initiation of
second line therapy.
Published: 25 May 2012
doi:10.1186/1742-4690-9-S1-P11
Cite this article as: Achappa et al.: Immunological response after
initiation of second line anti-retroviral therapy in HIV patients.
Retrovirology 2012 9(Suppl 1):P11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: bachu1504@gmail.com
† Contributed equally
Kasturba Medical College, Manipal University, Mangalore, India
Achappa et al. Retrovirology 2012, 9(Suppl 1):P11
http://www.retrovirology.com/content/9/S1/P11
© 2012 Achappa et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.